Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Income from Continuing Operations: 2020-2025

Historic Income from Continuing Operations for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -$29.4 million.

  • Caribou Biosciences' Income from Continuing Operations rose 23.11% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 3.88%. This contributed to the annual value of -$149.1 million for FY2024, which is 46.08% down from last year.
  • Latest data reveals that Caribou Biosciences reported Income from Continuing Operations of -$29.4 million as of Q3 2025, which was up 38.21% from -$47.6 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Income from Continuing Operations ranged from a high of -$13.2 million in Q1 2021 and a low of -$47.6 million during Q2 2025.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$38.2 million (2024), whereas its average is -$36.6 million.
  • In the last 5 years, Caribou Biosciences' Income from Continuing Operations plummeted by 664.48% in 2021 and then soared by 44.86% in 2023.
  • Quarterly analysis of 5 years shows Caribou Biosciences' Income from Continuing Operations stood at -$18.5 million in 2021, then tumbled by 65.47% to -$30.6 million in 2022, then dropped by 22.45% to -$37.4 million in 2023, then decreased by 3.83% to -$38.9 million in 2024, then grew by 23.11% to -$29.4 million in 2025.
  • Its Income from Continuing Operations stands at -$29.4 million for Q3 2025, versus -$47.6 million for Q2 2025 and -$42.9 million for Q1 2025.